Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen. With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.
Other News
- US-China trade war: How India can turn crisis into opportunity April 13, 2025 8:08 am The White House clarified that the levies on Chinese imports stand at 145 per cent—the 125 per cent tariff announced by President Donald Trump is in addition to the two hikes of 10 per cent post-Trump taking office. China’s unflinching approach has made …
- India's Pharma Industry Is Not Immune To The Spread Of AI March 25, 2025 11:18 pm -Analysis- NEW DELHI — With nearly one-fifth of the global supply chain and 60% of the worldwide vaccine supply, the Indian pharmaceutical industry is a dominant global player. India has the highest number of U.S. Food and Drug Administration-approved …
- Trump tariffs drive pharma manufacturing to US but risk inflation and disruption March 25, 2025 11:59 am The pharma industry has been left reeling by the recent news of US government trade tariffs, with companies Eli Lilly (Indianapolis, IN, US), Pfizer (New York, NY, US) and Merck & Co (Kenilworth, NJ, US) boosting their US manufacturing presence to …
- Alembic Pharmaceuticals completes USFDA inspection at Karakhadi API-III facility with zero observations March 22, 2025 4:55 am Alembic Pharmaceuticals Limited has successfully concluded a scheduled inspection by the United States Food and Drug Administration (USFDA) at its API-III manufacturing facility located in Karakhadi, Gujarat. The Good Manufacturing Practices (GMP) …
- The Future of Pharmaceutical Excipients: A $14 Billion Market Driven by Global Demand March 20, 2025 4:12 pm The pharmaceutical industry is undergoing a significant transformation, with excipients, active pharmaceutical ingredients (APIs), and functional excipients playing increasingly crucial roles in drug development and delivery. As we look towards the future, …
- DCAT Member Companies Present Latest News to Start DCAT Week 2025 March 17, 2025 8:17 pm Twenty companies from all corners of the bio/pharmaceutical industry provided updates on their latest developments at the inaugural event of the Drug, Chemical & Associated Technologies Association (DCAT)’s annual gathering, DCAT Week, at the …
- The NIFTY and the Sensex Trying To Rally amid Highly Volatile Global Trends: Market This week March 7, 2025 3:14 pm Indian benchmark indices closed relatively flat on Friday, ending their two-day winning streak. The BSE Sensex edged down 7.51 points (0.01%) to 74,332.58, while the Nifty 50 inched up 7.80 points (0.03%) to 22,552.50. Market sentiment remains cautious, …
- Stocks in news: TCS, Wipro, Dalmia Bharat, Zydus Life, LIC Housing, Hindustan Zinc & IRFC March 6, 2025 2:53 am Indian benchmark indices snapped the 10-day losing streak to settle with decent gains on Wednesday on the back of weakness in the US Dollar leading to a relief rally. BSE Sensex jumped 740.30 points, or 1.01 per cent, to end at 73,730.23. NSE's Nifty50 …
- Stocks To Watch: From TCS to Wipro- Here’s a list of 10 stocks in news today March 6, 2025 2:26 am Markets are always buzzing with action. Some of the biggest names in IT, finance, pharma, and infrastructure have announced key developments that could influence their stock performance. Whether it’s a new partnership, a major fundraising plan, or a …
- Fierce Pharma Asia—Eisai's US restructuring; China investigates former NMPA official; Pfizer-Summit collab February 28, 2025 4:19 pm Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by anti-corruption authorities. Pfizer has formed a clinical trial collaboration with Akeso's partner Summit Therapeutics. And …
- Global High Potency Active Pharmaceutical Ingredients Market to Surpass USD 45 Billion Mark by 2032 | DelveInsight February 27, 2025 11:38 pm The high-potency active pharmaceutical ingredients market is growing rapidly, driven mainly by the increasing global burden of chronic diseases. Key factors contributing to this expansion include the rising prevalence of cancer and diabetes, greater …
- Stocks in news: Bharti Airtel, Dr Reddy’s, BEL, UltraTech, Adani Green, Tata Power & SpiceJet February 27, 2025 2:48 am Ahead of Wednesday's holiday, Indian benchmark indices settled on a mixed note on Tuesday due to muted global cues and key economic data later this week amid the dull sentiments over valuations and tariff concerns. BSE Sensex gained 147.71 points, or 0 …
- Zealand Pharma Announces Financial Results for the Full Year 2024 February 20, 2025 6:00 am Company announcement – No. 2 / 2025 Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with significant clinical advancement across differentiated obesity pipeline, while building the foundation for accelerated …
- Stocks in news: Waaree Energies, Cyient, Bharat Forge, IREDA, Tata Tech, Patanjali & RITES February 20, 2025 2:51 am Indian benchmark indices settled slightly lower on Wednesday amid mixed global and domestic cues. BSE Sensex shed 28.21 points, or 0.04 per cent, to end at 75,939.18. NSE's Nifty50 declined 12.40 points, or 0.05 per cent, to settle at 22,932.90. Here …
- Stocks To Watch: From Bharat Forge to Waaree Energies- Here’s a list of 10 stocks in news today February 20, 2025 1:41 am Every trading day has its stars and strugglers. As the markets gear up for another trading session today, February 20, certain stocks are catching the spotlight. From major deals to policy shifts, here is a look at the stocks that are in focus. Market …
- Stocks in news: Wipro, BHEL, Shriram Finance, ABB India, RVNL Glenmark Pharma & ABFRL February 17, 2025 2:19 am Indian benchmark indices continued to tumble for the eight straight session and ended in red on Friday on the back of weak Q3 earnings, consistent FII selling, trade tariffs tantrums in the US. BSE Sensex shed 199.76 points, or 0.26 per cent, to end at 75, …
- Stocks in news: HFCL, BHEL, Glenmark Pharma, ABFRL, Wipro February 17, 2025 1:10 am Equity markets remained volatile on Friday, shedding nearly half a percent amid mixed cues. In today's trade, shares of HFCL, BHEL, Glenmark Pharma, ABFRL, Wipro among others will be in focus due to various news developments. HFCL Domestic telecom gear …
- Business News | India's CDMO Market Set to Double by 2028 Amid Asia's Healthcare Boom February 9, 2025 9:23 am New Delhi [India], February 9 (ANI): India's Contract Development and Manufacturing Organization (CDMO) market is poised for exponential growth, expected to expand from USD 7 billion to USD 14 billion by 2028, capturing 4-5 per cent of the global …
- Pharmaceutical Intermediates Global Market 2024 Report Highlights Strong Growth Potential February 6, 2025 11:05 pm Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! The Business Research Company presents the Pharmaceutical Intermediates Global Market Report 2024, which outlines the substantial growth potential …
- Sun Pharma shares in focus after Q3 profit beats estimates; Nuvama raises target price February 1, 2025 3:20 am Sun Pharma shares will be in focus on Saturday after the company reported a 15% year-on-year (YoY) increase in consolidated net profit to Rs 2,903 crore for the quarter ended December 2024. This includes an exceptional item of Rs 316 crore. The profit …
- Global Virology Market is Expected to Reach USD 3,808.9 Million by 2035, Driven by Developments in Antiviral Drugs, Diagnostics, and Vaccines | Future Market Insights, Inc. January 22, 2025 1:30 pm NEWARK, Del, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The virology market is projected to grow from USD 2,333.2 million in 2025 to USD 3,808.9 million by 2035, reflecting a compound annual growth rate (CAGR) of 5.0%. This growth is primarily attributed to the …
- INDIA API Market Gaining Ground at 8.50% CAGR to Reach 38.13 Billion USD by 2032 January 20, 2025 2:45 pm INDIA API Market Insights: India remains a leading producer of APIs, with robust growth in domestic and export demand. US, NY, UNITED STATES, January 20, 2025 /EINPresswire.com/ -- Market Research Future Latest Industry Insights on “India API …
- Avicanna Announces Scientific and Medical Affairs Collaboration with Vectura Fertin Pharma January 16, 2025 12:30 pm TORONTO, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based …
- Optimizing Outsourcing: A Case Study On Evaluating CDMO Capabilities For API And FD Development January 3, 2025 12:14 am (MENAFN- PR Newswire) A large Pharmaceutical company collaborated with DelveInsight to evaluate CDMO companies for API and FD development. DelveInsight provided a comprehensive one-time report benchmarking top contract development and manufacturing …
- Manappuram Finance, IPCA Labs, Torrent Pharma, V-Guard: SMC picks 4 stocks, says this December 23, 2024 6:43 am Amid the rising selling pressure in the Indian stock markets, domestic brokerage firm SMC Global Securities has suggested four stocks- IPCA Laboratories Ltd, V-Guard Industries Ltd, Torrent Pharmaceuticals Ltd and Manappuram Finance Ltd- to bet amid the …
- Lilly and EVA Pharma’s Locally Manufactured Insulin Approved in Egypt December 18, 2024 9:11 pm The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company. Launched in 2022, the collaboration aims to deliver a sustainable supply of high-quality, affordable human …
- Stocks in news: Mobikwik, Vishal Mega Mart, Ambuja Cements, Adani Energy, Auro Pharma & Sai Life December 18, 2024 2:44 am Indian benchmark indices settled with big cuts on Tuesday amid the pessimism of hawkish signals from the US Federal Reserve. BSE Sensex tanked 1,064.12 points, or 1.30 per cent, to end at 80,684.45. NSE's Nifty50 crashed 332.25 points or 1.35 per cent, …
- Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt December 17, 2024 11:18 am This milestone stems from the companies' collaboration to expand access to affordable insulin to one million people living with diabetes in low- to middle-income countries annually by 2030 INDIANAPOLIS and CAIRO, Dec. 17, 2024 /PRNewswire/ -- …
- New HSR Rules: Impacts to the Pharma Industry December 16, 2024 11:21 pm Click here to listen to the audio On this Ropes & Gray podcast, strategic transactions partner Hannah England is joined by antitrust partners Jackie Grise and Zak Goodwin to discuss the practical implications of the new Hart–Scott–Rodino (“HSR”) Act …
- Stocks in news: Wipro, Paytm, RITES, Welspun Corp, CEAT, Biocon, JSW Energy & Suven Pharma December 9, 2024 3:03 am Indian benchmark indices settled slightly lower on Friday after the RBI's monetary policy, snapping the five-day winning streak. BSE Sensex fell 56.74 points or 0.07 per cent to end at 81,709.12. NSE's Nifty50 eased 30.60 points or 0.12 per cent, …
- Fierce Pharma Asia—Sanofi's $1B manufacturing base; GSK's ADC deal, Shingrix recalibration in China December 6, 2024 6:53 pm Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in Singapore. GSK inked an antibody-drug conjugate deal with DualityBio and, through a revised agreement with Zhifei, dialed down its …
- Active Pharmaceutical Ingredients Market To Grow By USD 86.47 Billion (2024-2028), Driven By Evolving API Manufacturing, With AI Driving Market Transformation - Technavio December 3, 2024 12:39 am (MENAFN- PR Newswire) NEW YORK, Dec. 2, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global active Pharmaceutical ingredients market size is estimated to grow by USD 86.47 billion from 2024-2028, according to Technavio. The …
- Clariant to showcase made in India pharma products at CPHI 2024 November 26, 2024 9:38 am Clariant is excited to present the company’s latest portfolio of products for the healthcare industry at the upcoming CPHI India tradeshow in Delhi NCR on November 26 through 28, 2024. This year’s event will showcase Clariant Health Care’s Made in India …
- Stocks in news: Waaree Energies, GMR Infra, AstraZeneca, Indus Towers, Ashoka Buildcon & ITI November 19, 2024 3:09 am Indian benchmark indices settled lower on Monday, marking losses for the seventh straight session. A muted earnings season, and mixed global cues dented the sentiments at Dalal Street. BSE Sensex shed 241.30 points or 0.31 per cent to end at 77,339.01. NSE …
- Global Plant-Based API Market Set to Reach USD 52,085.9 Million by 2034, Expected to Grow at a CAGR of 5.6% | Future Market Insights, Inc. November 14, 2024 4:30 pm NEWARK, Del, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The global plant-based API market is expected to experience robust growth, with a projected value of USD 30,084.8 million in 2024, expanding at a compound annual growth rate (CAGR) of 5.6% through 2034, …
- Tryptamine API Market is Set to Reach $2.25 Billion with 11.5% CAGR by 2034 | Fact.MR Report November 6, 2024 12:30 pm Rockville, MD, Nov. 06, 2024 (GLOBE NEWSWIRE) -- According to a new industry report by Fact.MR, the global tryptamine API market is projected to be worth US$ 757.2 million in 2024 and thereafter advance at 11.5% CAGR from 2024 to 2034. Tryptamine possesses …
- Piramal Pharma Limited Announces Results for Q2 and H1 FY25 October 23, 2024 6:55 pm MUMBAI, Oct. 23, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year ( …
- LGM Pharma Expands Its Analytical Testing Services October 15, 2024 1:44 pm Breaking News Adds endotoxin and rapid sterility testing capabilities to benefit drug developers. 10.15.24 LGM Pharma, a provider of tailored API and CDMO services for the full drug product lifecycle, has expanded its Analytical Testing Services (ATS) with …
- India News | JP Nadda Inaugurates International Conference of Drug Regulatory Authorities, Highlights India's Contributions to Global Health Security October 14, 2024 1:16 pm New Delhi [India], October 14 (ANI): Union Health Minister JP Nadda on Monday inaugurated the 19th International Conference of Drug Regulatory Authorities and said that the ICDRA platform provides a space to share knowledge, foster partnerships and develop …
- CPHI Milan Announces Winners of 2024 CPHI Pharma Awards October 9, 2024 4:20 pm CPHI Milan has announced the winners of the prestigious 2024 CPHI Pharma Awards, celebrating the brightest minds and most innovative advancements across the global pharmaceutical industry. This year’s awards spanned 14 categories, including two new …
- Pharma Fridays – October 4, 2024 October 4, 2024 5:45 pm An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Priority Review Granted for HER2-low or HER2-ultralow Metastatic Breast Cancer Treatment On October 1, AstraZeneca and Daiichi Sankyo announced that its …
- Sterling Pharma, Soligenix Partner to Manufacture Oncology API October 4, 2024 2:14 pm Breaking News Sterling to manufacture a GMP-quality synthetic hypericin developed by Soligenix for its oncology drug, HyBryte. 10.04.24 Sterling Pharma Solutions, a global contract development and manufacturing organization, and Soligenix, a late-stage …
- Stocks in news: Ola Electric, BSE, Bajaj Finance, RPower, CESC, Bank of Baroda, DMart & Godawari Power October 4, 2024 3:01 am Indian benchmark indices saw an intense sell-off on Thursday on the back of rising geopolitical concerns, intense FIIs selling and a reaction to SEBI's F&O curbs. BSE Sensex crashed 1,769.19 points or 2.10 per cent, to end at 82,497.10. NSE's …
- C2 PHARMA Expands Ophthalmic Portfolio October 1, 2024 8:37 pm Breaking News Plans several more product launches for the upcoming year. 10.01.24 C2 PHARMA, a leader in manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs), recently launched Naphazoline Hydrochloride, expanding its …
- Sensex drops 1272 pts, Nifty ends below 25,850 amid mixed global cues September 30, 2024 2:57 pm Domestic equity benchmarks experienced a sharp decline today, mirroring global trends, as tensions in the Middle East escalated. The Nifty50 closed below 25,850, with sectors like auto, banking, and finance bearing the brunt of the sell-off. However, …
- Stocks in news: Manba, Dr Reddy's, PNB, Zomato, IDFC First, BEL, Tata Motors & ICICI Pru September 30, 2024 3:02 am Indian benchmark indices settled lower on Friday on the back of profit booking by the traders during the fag-end session. BSE Sensex dropped 264.27 points or 0.31 per cent, to end the session at 85,571.85. NSE's Nifty50 shed 37.10 points, or 0.14 per …
- The pharma& Group Enters into an Exclusive Promotional Agreement with Tolmar, Inc. to Promote Rubraca® (rucaparib) in the U.S. for the Treatment of Metastatic Castration-Resistant Prostate Cancer September 25, 2024 9:01 am VIENNA and BUFFALO GROVE, Ill., Sept. 24, 2024 /PRNewswire/ -- pharmaand GmbH (pharma&) and Tolmar, Inc. (Tolmar) announced today an exclusive agreement for Tolmar to promote Rubraca (rucaparib) in the U.S. for the treatment of metastatic …
- Levothyroxine Sodium API Market Size to Grow USD 42 Million by 2030 at a CAGR of 4.5% | Valuates Reports September 24, 2024 3:00 pm BANGALORE, India, Sept. 24, 2024 /PRNewswire/ -- Levothyroxine Sodium API Market is Segmented by Type (EP, USP), by Application (Oral, Injection): Global Opportunity Analysis and Industry Forecast, 2024-2030. The Global Levothyroxine Sodium API …
- Stocks in news: RIL, HDFC Bank, Adani Ports, BHEL, Adani Gas, Voda Idea, ONGC, Tata Steel & HFCL September 23, 2024 2:44 am Indian benchmark indices joined the global rally on Friday, triggered by the US Fed's rate cuts and positive global cues. BSE Sensex soared 1,359.51 points or 1.63 per cent, to end at 84,544.31. NSE's Nifty50 zoomed 375.15 points, or 1.48 per cent, …
- Stocks in news: SpiceJet, Mankind Pharma, Vodafone Idea, Aarti Drugs, BHEL, RIL September 23, 2024 1:48 am Domestic markets edged higher on Friday, gaining nearly one and a half percent, largely tracking global trends. In today's trade, shares of SpiceJet, Mankind Pharma, Vodafone Idea, Aarti Drugs, BHEL, RIL among others will be in focus due to various …